Metabiota in Modern Insurance Magazine: Industry Innovators Interview

Metabiota’s mission is to make the world more resilient to epidemics. Following the impact of Covid-19, change is on the horizon as the need to cover risk becomes ever more prevalent. Nita Madhav, CEO of Metabiota, discusses Metabiota’s work and ability to mitigate against the outbreaks. Epidemic risk factors will only continue to escalate across the globe, and Metabiota is working hard to inform the industry of the data and tools available that could help them mitigate against future epidemic and pandemic risks and their consequences.  View full article in Modern Insurance Magazine.

Metabiota in the Cameroon Tribune: MINDEF: Minister Encourages Army Health Research Centre

The Minister Delegate at the Presidency in charge of Defence, Joseph Beti Assomo paid a working visit to the Army Health Research Centre (CRESAR) and Metabiota teams on October 15, 2020, a culmination of 20 years of successful collaborative efforts.   CRESAR began in 2000 with a mission to carry out research and laboratory testing for the Defence Forces, their families, and other populations in Cameroon. Together with Metabiota, CRESAR has contributed enormously to public health in the military and general Cameroonian population.  View full article in Cameroon Tribune. 

Metabiota in Homeland Preparedness News: Bipartisan Commission on Biodefense prepares for next pandemic

The ongoing COVID-19 pandemic is revealing major gaps in national readiness to prepare for, respond to, and recover from biological threats, requiring that decision makers consider improved policies, programs, and technologies to ramp up the federal defense, experts said during the Sept. 24 virtual meeting of the Bipartisan Commission on Biodefense. View article for more information on the Bipartisan Commission on Biodefense and Metabiota.

Metabiota in S&P Global Market Intelligence: Human behavior biggest challenge in race to model pandemic risk

Capturing how individuals and governments respond to pandemics is one of the key challenges to developing risk models that could underpin future insurance solutions, according to specialists. View article in S&P Global Market Intelligence:  Human behavior biggest challenge in race to model pandemic risk

Metabiota in Insurance Day: Not so unexpected? Modelling pandemic risks

It is possible for insurers and clients to estimate potential losses caused by events like Covid-19, the chief executive of San Francisco-based Metabiota says...  View article in Insurance Day: Not so unexpected? Modelling pandemic risks

Metabiota joins Lloyd's Lab for COVID-19 Cohort

Metabiota is delighted to join Lloyd's Lab's Cohort 5 to support the markets in responding to COVID-19 and future pandemics. We'll work closely with Lloyd's to provide epidemic risk data, indices, modeling and other analytic tools to support development of innovative epidemic-related insurance coverage.  To read more about Lloyd's Lab's Cohort 5, click here.   

Metabiota in Wired: We Can Protect the Economy From Pandemics. Why Didn't We?

A virologist helped crack an impossible problem: how to insure against the economic fallout from devastating viral outbreaks. The plan was ingenious. Yet we're still in this mess. Metabiota in Wired: We Can Protect the Economy From Pandemics. Why Didn't We?

Metabiota in Brookings: AI: The complex solution to simplify health care

Health care languishes in data dissonance. A fundamental imbalance between collection and use persists across systems and geopolitical boundaries. Data collection has been an all-consuming effort with good intent but insufficient results in turning data into action. After a strong decade, the sentiment is that the data is inconsistent, messy, and untrustworthy. The most advanced health systems in the world remain confused by what they’ve amassed: reams of data without a clear path toward impact. Artificial intelligence (AI) can see through the murk, clear away the noise, and find meaning in existing data beyond the capacity of any human(s) or other technology. Organizations like Metabiota have mapped thousands of pandemics to generate a model for risk. Existing electronic information systems (EIS) hold valuable historical health data when they are available—both pandemic models and EIS are excellent sources for AI engines targeted at optimization of pandemic response at scale. View article on Brookings: AI: The complex solution to simplify health care

Metabiota at Wall Street Journal Tech Health: Deep Dive: Tracking and Detecting an Epidemic

Kamran Khan, CEO of BlueDot and Nita Madhav, CEO of Metabiota discuss how AI tracked the spread of the new coronavirus at WSJ Tech Health. Metabiota at WSJ Tech Health Deep Dive: Tracking and Detecting an Epidemic

Metabiota in TIME: COVID-19 Won't Be the Last Pandemic. Here's What We Can Do to Protect Ourselves

COVID-19 will not be the last pandemic in our deeply interconnected world, and sadly it won’t be the worst. Two profoundly different possible futures are available to us: one in which we stick our heads in the sand as we have consistently done, and one where humanity takes the hard, necessary steps to protect itself. View Article on Time: COVID-19 Won't Be the Last Pandemic. Here's What We Can Do to Protect Ourselves